1-20 of 22
Charles N. Landen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial

Charles N. Landen, Luciana Molinero, Habib Hamidi, Jalid Sehouli, Austin Miller, Kathleen N. Moore, Cagatay Taskiran, Michael Bookman, Kristina Lindemann, Charles Anderson, Regina Berger, Tashanna Myers, Mario Beiner, Thomas Reid, Els Van Nieuwenhuysen, Andrew Green, Aikou Okamoto, Carol Aghajanian, Premal H. Thaker, Stephanie V. Blank, Victor K. Khor, Ching-Wei Chang, Yvonne G. Lin, Sandro Pignata
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (9): 1698–1707.
https://doi.org/10.1158/1078-0432.CCR-22-2032
Published: 01 May 2023
View articletitled, Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Open the PDF for Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Aparna A. Kamat, Mavis Fletcher, Lynn M. Gruman, Peter Mueller, Adriana Lopez, Charles N. Landen, Jr., Liz Han, David M. Gershenson, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (15): 4455.
https://doi.org/10.1158/1078-0432.CCR-21-2121
Published: 01 August 2021
View articletitled, Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Open the PDF for Editor's Note: The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer in another window
Journal Articles

Abstract B31: Endocervical microRNA profiling for detection of ovarian cancer

Alexandra R. Harris, Danielle C. Llaneza, Mark R. Conaway, Thomas P. Conrads, Katherine Croft, John R. Cornelison, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (13_Supplement): B31.
https://doi.org/10.1158/1557-3265.OVCA19-B31
Published: 01 July 2020
View articletitled, Abstract B31: Endocervical microRNA profiling for detection of ovarian cancer
Journal Articles

Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Jyotsnabaran Halder, Aparna A. Kamat, Charles N. Landen, Jr, Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3194.
https://doi.org/10.1158/1078-0432.CCR-19-1132
Published: 15 May 2019
View articletitled, Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy
Open the PDF for Correction: Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy in another window
Journal Articles

Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer

Robert Cornelison, Zachary C. Dobbin, Ashwini A. Katre, Dae Hoon Jeong, Yinfeng Zhang, Dongquan Chen, Yuliya Petrova, Danielle C. Llaneza, Adam D. Steg, Laura Parsons, David A. Schneider, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (21): 6529–6540.
https://doi.org/10.1158/1078-0432.CCR-17-0282
Published: 31 October 2017
View articletitled, Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer
Open the PDF for Targeting RNA-Polymerase I in Both Chemosensitive and Chemoresistant Populations in Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer

Zachary Dobbin, Robert Cornelison, Ashwini K. Katre, David A. Schneider, Karen Watters, Fabian Coscia, Ernst Lengyel, Aaron Buechlein, Fang Fang, Kenneth Nephew, Charles N. Landen, Jr
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B39.
https://doi.org/10.1158/1557-3265.PDX16-B39
Published: 15 August 2016
View articletitled, Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer
Journal Articles

Abstract A83: Profiling potent, novel protein tyrosine phosphatase 4A3 small molecule inhibitors for ovarian cancer.

Elizabeth R. Sharlow, Joseph M. Salamoun, Kelley E. McQueeney, Sophie Lewandowski, Jennifer Bryant, Alex Cheung, Paula Pekic, Charles N. Landen, Jr, Peter Wipf, John S. Lazo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A83.
https://doi.org/10.1158/1557-3265.OVCA15-A83
Published: 15 January 2016
View articletitled, Abstract A83: Profiling potent, novel protein tyrosine phosphatase 4A3 small molecule inhibitors for ovarian cancer.
Journal Articles

Abstract A78: Control of tumor cell survival mechanisms by a novel glycan-modifying enzyme

Matthew J. Schultz, Zhongyu Liu, Charles N. Landen, Susan L. Bellis
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A78.
https://doi.org/10.1158/1078-0432.OVCA13-A78
Published: 13 May 2014
View articletitled, Abstract A78: Control of tumor cell survival mechanisms by a novel glycan-modifying enzyme
Journal Articles

Abstract A58: An ovarian patient-derived xenograft model to identify the chemoresistant population

Zachary C. Dobbin, Ashwini K. Katre, Monjri M. Shah, Britt K. Erickson, Hauping Chen, Ronald D. Alvarez, Michael G. Conner, Dongquan Chen, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): A58.
https://doi.org/10.1158/1078-0432.OVCA13-A58
Published: 13 May 2014
View articletitled, Abstract A58: An ovarian patient-derived xenograft model to identify the chemoresistant population
Journal Articles

Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer

Angela J. Ziebarth, Somaira Nowsheen, Adam D. Steg, Monjri M. Shah, Ashwini A. Katre, Zachary C. Dobbin, Hee-Dong Han, Gabriel Lopez-Berestein, Anil K. Sood, Michael Conner, Eddy S. Yang, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (1): 170–182.
https://doi.org/10.1158/1078-0432.CCR-12-1045
Published: 02 January 2013
View articletitled, Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer
Open the PDF for Endoglin (CD105) Contributes to Platinum Resistance and Is A Target for Tumor-Specific Therapy in Epithelial Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer

Adam D. Steg, Kerri S. Bevis, Ashwini A. Katre, Angela Ziebarth, Zachary C. Dobbin, Ronald D. Alvarez, Kui Zhang, Michael Conner, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3): 869–881.
https://doi.org/10.1158/1078-0432.CCR-11-2188
Published: 31 January 2012
View articletitled, Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Open the PDF for Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer

Adam D. Steg, Ashwini A. Katre, Blake Goodman, Hee-Dong Han, Alpa M. Nick, Rebecca L. Stone, Robert L. Coleman, Ronald D. Alvarez, Gabriel Lopez-Berestein, Anil K. Sood, Charles N. Landen
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (17): 5674–5685.
https://doi.org/10.1158/1078-0432.CCR-11-0432
Published: 01 September 2011
View articletitled, Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
Open the PDF for Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer in another window
Journal Articles

Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth

Yvonne G. Lin, Anand Immaneni, William M. Merritt, Lingegowda S. Mangala, Seung Wook Kim, Mian M.K. Shahzad, Yvonne T.M. Tsang, Guillermo N. Armaiz-Pena, Chunhua Lu, Aparna A. Kamat, Liz Y. Han, Whitney A. Spannuth, Alpa M. Nick, Charles N. Landen, Jr., Kwong K. Wong, Michael J. Gray, Robert L. Coleman, Diane C. Bodurka, William R. Brinkley, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (17): 5437–5446.
https://doi.org/10.1158/1078-0432.CCR-07-4922
Published: 02 September 2008
View articletitled, Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth
Open the PDF for Targeting Aurora Kinase with MK-0457 Inhibits Ovarian Cancer Growth in another window
Includes: Supplementary data
Journal Articles

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Liz Y. Han, Mavis S. Fletcher, Diana L. Urbauer, Peter Mueller, Charles N. Landen, Aparna A. Kamat, Yvonne G. Lin, William M. Merritt, Whitney A. Spannuth, Michael T. Deavers, Koen De Geest, David M. Gershenson, Susan K. Lutgendorf, Soldano Ferrone, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3372–3379.
https://doi.org/10.1158/1078-0432.CCR-07-4433
Published: 02 June 2008
View articletitled, HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
Open the PDF for HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma in another window
Journal Articles

Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer

Aparna A. Kamat, William M. Merritt, Donna Coffey, Yvonne G. Lin, Pooja R. Patel, Russell Broaddus, Elizabeth Nugent, Liz Y. Han, Charles N. Landen, Jr., Whitney A. Spannuth, Chunhua Lu, Robert L. Coleman, David M. Gershenson, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (24): 7487–7495.
https://doi.org/10.1158/1078-0432.CCR-07-1017
Published: 19 December 2007
View articletitled, Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
Open the PDF for Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer in another window
Journal Articles

Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients

Charles N. Landen, Jr., Yvonne G. Lin, Anand Immaneni, Michael T. Deavers, William M. Merritt, Whitney A. Spannuth, Diane C. Bodurka, David M. Gershenson, William R. Brinkley, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4098–4104.
https://doi.org/10.1158/1078-0432.CCR-07-0431
Published: 18 July 2007
View articletitled, Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients
Open the PDF for Overexpression of the Centrosomal Protein Aurora-A Kinase is Associated with Poor Prognosis in Epithelial Ovarian Cancer Patients in another window
Journal Articles

Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma

Chunhua Lu, Aparna A. Kamat, Yvonne G. Lin, William M. Merritt, Charles N. Landen, Tae Jin Kim, Whitney Spannuth, Thiru Arumugam, Liz Y. Han, Nicholas B. Jennings, Craig Logsdon, Robert B. Jaffe, Robert L. Coleman, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4209–4217.
https://doi.org/10.1158/1078-0432.CCR-07-0197
Published: 18 July 2007
View articletitled, Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma
Open the PDF for Dual Targeting of Endothelial Cells and Pericytes in Antivascular Therapy for Ovarian Carcinoma in another window
Journal Articles

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Jyotsnabaran Halder, Aparna A. Kamat, Charles N. Landen, Jr., Liz Y. Han, Susan K. Lutgendorf, Yvonne G. Lin, William M. Merritt, Nicholas B. Jennings, Arturo Chavez-Reyes, Robert L. Coleman, David M. Gershenson, Rosemarie Schmandt, Steven W. Cole, Gabriel Lopez-Berestein, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (16): 4916–4924.
https://doi.org/10.1158/1078-0432.CCR-06-0021
Published: 16 August 2006
View articletitled, Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy
Open the PDF for Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy in another window
Journal Articles

The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer

Aparna A. Kamat, Mavis Fletcher, Lynn M. Gruman, Peter Mueller, Adriana Lopez, Charles N. Landen, Jr., Liz Han, David M. Gershenson, Anil K. Sood
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1707–1714.
https://doi.org/10.1158/1078-0432.CCR-05-2338
Published: 21 March 2006
View articletitled, The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Open the PDF for The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer in another window
Journal Articles

Stress Hormone–Mediated Invasion of Ovarian Cancer Cells

Anil K. Sood, Robert Bhatty, Aparna A. Kamat, Charles N. Landen, Liz Han, Premal H. Thaker, Yang Li, David M. Gershenson, Susan Lutgendorf, Steven W. Cole
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (2): 369–375.
https://doi.org/10.1158/1078-0432.CCR-05-1698
Published: 20 January 2006
View articletitled, Stress Hormone–Mediated Invasion of Ovarian Cancer Cells
Open the PDF for Stress Hormone–Mediated Invasion of Ovarian Cancer Cells in another window